Vanguard FTSE 100 UCITS ETF
(VUKE) Vanguard FTSE 100 UCITS ETF - (GBP) Distributing
Related documents
About this fund
Fund objectives
- The Fund employs a passive management – or indexing – investment approach, through physical acquisition of securities, and seeks to track the performance of the FTSE 100 Index (the “Index”).
- The Index is comprised of large-sized company stocks in the UK.
- The Fund attempts to: 1. Track the performance of the Index by investing in all constituent securities of the Index in the same proportion as the Index. Where not practicable to fully replicate, the Fund will use a sampling process. 2. Remain fully invested except in extraordinary market, political or similar conditions.
Why this fund
- The Fund seeks to track the performance of the index, a widely recognised UK benchmark of the 100 most highly capitalised blue chip companies, representing approximately 83% of the UK market.
- The Fund employs a “passive management” or indexing investment approach, through physical acquisition of securities, designed to track the performance of the index, a free-float-adjusted market-capitalisation-weighted index.
- In tracking the performance of the index, the Fund attempts to replicate the index by investing all, or substantially all, of its assets in the stocks that make up the index, holding each stock in approximately the same proportion as its weighting in the index.
Fund facts
Share class inception
May 22 2012
Listing date
May 23 2012
Investment structure
Irish UCITS
Share class assets'
Total assets
Risk indicator
Strategy
Index
Asset class
Equity
Investment Method
Physical
Index ticker
UKXNUK
Benchmark
FTSE 100 Index
Dividend Schedule
Quarterly
Tax status
Austria, Germany, Switzerland and United Kingdom
Domicile
Ireland
Legal Entity
Vanguard Funds PLC
The value of investments, and the income from them, may fall or rise and investors may get back less than they invested.
Performance
Risk and Volatility
As at Sep 30 2026
Beta
R²
Alpha
Standard Deviation
Sharpe Ratio
Please note Beta and R-squared data will only display for funds with 3 full years of history.
The value of investments, and the income from them, may fall or rise and investors may get back less than they invested.
Portfolio data
Characteristics
| Fundamentals | Fund | Benchmark | As at |
|---|---|---|---|
| Number of stocks | 104 | 100 | Sep 30 2026 |
| Median market capital | 62.2 B | 62.2 B | Sep 30 2026 |
| 15.1 x | 15.1 x | Sep 30 2026 | |
| 2.2 x | 2.2 x | Sep 30 2026 | |
| 11.9% | 11.9% | Sep 30 2026 | |
| 9.1% | 9.1% | Sep 30 2026 | |
| Portfolio turnover rate | -22.3% | — | Sep 30 2026 |
Market allocation
As at Sep 30 2026
| Country | Region | Fund | Benchmark | Variance +/- |
|---|---|---|---|---|
| United Kingdom | Europe | 99.82% | 100.00% | -0.18% |
| Guernsey, C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I. | Europe | 0.18% | — | — |
Top 10 Holdings
As at Sep 30 2026
| Holding name | % of market value | Sector | Region | Market value | Shares |
|---|---|---|---|---|---|
| HSBC Holdings PLC | 10.10289% | Financials | GB | £660,387,686.40 | 44,096,400 |
| Shell PLC | 8.19586% | Energy | GB | £535,731,941.31 | 15,008,599 |
| AstraZeneca PLC | 7.24072% | Health Care | GB | £473,298,093.20 | 3,854,219 |
| Rolls-Royce Holdings PLC | 4.82189% | Industrials | GB | £315,188,719.78 | 21,564,636 |
| Unilever PLC | 3.76267% | Consumer Staples | GB | £245,951,700.89 | 5,342,711 |
| BP PLC | 3.38856% | Energy | GB | £221,497,537.93 | 40,316,261 |
| British American Tobacco PLC | 3.29546% | Consumer Staples | GB | £215,411,829.34 | 5,217,046 |
| Rio Tinto PLC | 2.88863% | Basic Materials | GB | £188,818,989.03 | 2,659,797 |
| GSK PLC | 2.87308% | Health Care | GB | £187,802,240.48 | 10,251,214 |
| Lloyds Banking Group PLC | 2.46082% | Financials | GB | £160,854,679.18 | 150,472,104 |
Prices and distribution
Prices
NAV Price (GBP)
£46.90
GBPChange
+£0.521.11% As at Oct 15 2026
Market price (GBP)
£47.17
Change
+£0.190.40% As at Oct 16 2026
NAV 52-week high
£47.42
As at Oct 16 2026
Market price 52-week high
£47.60
As at Oct 16 2026
NAV 52-week low
£40.55
As at Oct 16 2026
Market price 52-week low
£40.72
As at Oct 16 2026
NAV 52-week difference
£6.86
Change
+14.47% As at Oct 16 2026
Market price 52-week difference
£6.88
Change
+14.44% As at Oct 16 2026
Outstanding shares
100,196,719
As at Sep 30 2026
Discount
£0.27
Change
+0.58% As at Oct 16 2026
Historical Prices
-
Inception date
May 22 2012
Listing date
May 23 2012
| Date | NAV (GBP) | Market price (GBP) |
|---|---|---|
| Oct 16 2026 | — | £47.1700 |
| Oct 15 2026 | £46.8976 | £46.9800 |
| Oct 14 2026 | £46.3805 | £46.4700 |
| Oct 13 2026 | £46.0581 | £46.1550 |
| Oct 12 2026 | £46.0838 | £46.1550 |
| Oct 09 2026 | £45.6337 | £45.7250 |
| Oct 08 2026 | £45.1562 | £45.2450 |
| Oct 07 2026 | £45.2260 | £45.3400 |
| Oct 06 2026 | £45.5857 | £45.6700 |
| Oct 05 2026 | £45.3964 | £45.4700 |
Distribution history
Distribution frequency
Quarterly
Historical performance Sep 30 2026
3.15%
| Type | Distribution amount (per unit) | Ex-dividend date | Record date | Payment date |
|---|---|---|---|---|
| Income | £0.3968 | Sep 17 2026 | Sep 18 2026 | Sep 30 2026 |
| Income | £0.4532 | Jun 18 2026 | Jun 19 2026 | Jul 01 2026 |
| Income | £0.3620 | Mar 19 2026 | Mar 20 2026 | Apr 01 2026 |
| Income | £0.2297 | Dec 18 2025 | Dec 19 2025 | Dec 31 2025 |
| Income | £0.3641 | Sep 18 2025 | Sep 19 2025 | Oct 01 2025 |
| Income | £0.4017 | Jun 19 2025 | Jun 20 2025 | Jul 02 2025 |
| Income | £0.3535 | Mar 20 2025 | Mar 21 2025 | Apr 02 2025 |
| Income | £0.2101 | Dec 12 2024 | Dec 13 2024 | Dec 27 2024 |
| Income | £0.3380 | Sep 12 2024 | Sep 13 2024 | Sep 25 2024 |
| Income | £0.5586 | Jun 13 2024 | Jun 14 2024 | Jun 26 2024 |
Purchase information
Currencies and stock exchanges
Listed currencies: GBP, CHF, EUR, MXN
Base currency:GBP
Exchanges: London Stock Exchange, SIX Swiss Exchange, Deutsche Boerse, Bolsa Mexicana De Valores, Borsa Italiana S.p.A.